Steroid containing fixed drug combinations banned by government of India: A big step towards dermatologic drug safety

Steroid containing fixed drug combinations banned by government of India: A big step towards dermatologic drug safety

Bibliographic Details
Main Author:	Sushil Pande
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-01-01
Series:	Indian Journal of Drugs in Dermatology
Online Access:	http://www.ijdd.in/article.asp?issn=2455-3972;year=2016;volume=2;issue=1;spage=1;epage=2;aulast=Pande

Similar Items

Causality or Relatedness assessment in adverse drug reaction and its relevance in dermatology
by: Sushil Pande
Published: (2018-01-01)

Banned drugs: Still available in India
by: Manjari Gupta, et al.
Published: (2011-01-01)

Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs.
by: Patricia McGettigan, et al.
Published: (2015-05-01)

Fixed drug eruption at a dermatology clinic in Lagos, Nigeria
by: Olusola Olabisi Ayanlowo
Published: (2015-01-01)

Food and drug interactions in dermatology: Maximizing drug safety and efficacy through intelligent dispensing
by: Anwita Sinha, et al.
Published: (2021-01-01)

India’s ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?
by: Gandra, S., et al.
Published: (2022)

Generalized bullous fixed drug reaction: A close similarity to stevens–johnson syndrome
by: Bhagyashri Daulatabadkar, et al.
Published: (2017-01-01)

Pharmacovigilance: What dermatology physicians should know?
by: Sudhir Bansod, et al.
Published: (2015-01-01)

Recent drug approvals in dermatology
Published: (2015-01-01)

Nanoemulsions for dermatological drug delivery
by: Kim, Jung Hak
Published: (2009)

Steroid pulse therapies in dermatology
by: Gaurang Gupta, et al.
Published: (2014-01-01)

ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
by: N. Yu. Velts, et al.
Published: (2018-09-01)

APPLICATION OF DRUG-RELATED PROBLEMS APPROACH TO ANALYSIS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS’ SAFETY
by: A. V. Matveev, et al.
Published: (2019-09-01)

Foam drug delivery in dermatology: beyond the scalp
by: Purdon, C H, et al.
Published: (2003)

A Case of phenytoin drug hypersensitivity syndrome
by: Sushil Pande, et al.
Published: (2015-01-01)

Knowledge, attitude, and practice of adverse drug reaction, and adverse drug reaction reporting among practising dermatologists in Maharashtra: A questionnaire-based survey
by: Sushil Pande, et al.
Published: (2020-01-01)

Evaluation of the analgesic and anti-inflammatory activity of fixed dose combination: Non-steroidal anti-inflammatory drugs in experimental animals
by: Amit Lahoti, et al.
Published: (2014-01-01)

Colchicine in dermatology: Rediscovering an old drug with novel uses
by: Kabir Sardana, et al.
Published: (2020-01-01)

Ocular side effects of systemic drugs used in dermatology
by: Bhanu Prakash, et al.
Published: (2019-01-01)

Drug interactions in dermatology: What the dermatologist should know
by: Arijit Coondoo, et al.
Published: (2013-01-01)

Formulation of novel surfactant vesicles for dermatological drug delivery
by: Benetton, Salete Aparecida
Published: (1995)

Treatment of adverse drug reactions in a dermatology department
by: Ganeva Maria, et al.
Published: (2011-02-01)

Drug Release and Skin Permeation Kineticks of Steroidal Drugs
by: Liu Wen Liang, et al.
Published: (1994)

Steroidal antiinflammatory drugs: glucocorticoids
by: Sônia Maria Alvarenga Anti, et al.
Published: (2008-03-01)

The metabolism of drugs and steroids in the placenta
by: Hopkins, Robert
Published: (1973)

Growth Of Dermatology In India
by: Percival G.H
Published: (2001-01-01)

Safety and Efficacy of Fixed Drug Combination Tenofovir, Lamivudine and Efavirenz to Prevent Transmission of HIV
by: Pramendra Sirohi, et al.
Published: (2021-07-01)

Stability of Positively Charged Nanoemulsion Formulation Containing Steroidal Drug for Effective Transdermal Application
by: Stephanie Da Costa, et al.
Published: (2014-01-01)

Expert committee to formulate policy and guidelines for approval of new drugs, clinical trials and banning of drugs-comments
by: Ravindra B. Ghooi
Published: (2014-01-01)

Drug-induced urticaria due to cephalosporins: A case-based learning
by: Sushil Pande, et al.
Published: (2016-01-01)

Magnitude, characteristics and consequences of topical steroid misuse in rural North India: an observational study among dermatology outpatients
by: Molly Thomas, et al.
Published: (2020-05-01)

Dermatology in India and Indian dermatology: A Medico-Historical perspective
by: Amiya K Mukhopadhyay
Published: (2016-01-01)

Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting
by: Oriana Simonetti, et al.
Published: (2021-04-01)

Electronic cigarettes and its ban in India
by: S M Balaji
Published: (2019-01-01)

Prevalence of Skin Drug Eruptions in Dermatology Departments of Tehran Hospitals
by: Saviz Saghari, et al.
Published: (2012-03-01)

New changes in pregnancy and lactation labelling: Review of dermatologic drugs
by: Yun Pei Koh, MBBS, et al.
Published: (2019-09-01)

Safety of selective non-steroidal anti-inflammatory drugs: analysis of the last years data
by: N. A. Shostak, et al.
Published: (2020-05-01)

Cardiovascular safety of non-steroidal anti-inflammatory drugs in chronic inflammatory rheumatic diseases
by: B V Zavodovsky, et al.
Published: (2018-08-01)

Use of topical steroids in dermatology: A questionnaire based study
by: Sonali R Karekar, et al.
Published: (2020-01-01)

Postcoital fixed drug eruption: A rare pattern of fixed drug eruption
by: Sudip Das, et al.
Published: (2020-01-01)